Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference.

Q1 Medicine

Medical Cannabis and Cannabinoids Pub Date : 2022-10-17 eCollection Date: 2022-01-01 DOI:10.1159/000527080

Nicole E Smolinski, Ruba Sajdeya, Robert Cook, Yan Wang, Almut G Winterstein, Amie Goodin

{"title":"Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference.","authors":"Nicole E Smolinski, Ruba Sajdeya, Robert Cook, Yan Wang, Almut G Winterstein, Amie Goodin","doi":"10.1159/000527080","DOIUrl":null,"url":null,"abstract":"<p><p>The Consortium for Medical Marijuana Clinical Outcomes Research, a multi-university collaboration established by the state of Florida in the USA, hosted its second annual Cannabis Clinical Outcomes Research Conference (CCORC) in May 2022. CCORC was held as a hybrid conference, with a scientific program consisting of in-person and virtual sessions. CCORC fostered and disseminated current research on clinical outcomes of medical marijuana while stimulating collaboration and engagement between the scientific community, policymakers, industry representatives, clinicians, and other interested stakeholders. Three themes emerged from conference sessions and speakers: (1) disentangling research findings comparing use and outcomes of medical and nonmedical cannabis, (2) addressing barriers and promoting facilitators for clinical cannabis research, and (3) resolving uncertainties around cannabis dosing. The third annual CCORC is planned for the summer of 2023 in Florida, USA.</p>","PeriodicalId":18415,"journal":{"name":"Medical Cannabis and Cannabinoids","volume":" ","pages":"138-141"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9f/ab/mca-0005-0138.PMC9710315.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Cannabis and Cannabinoids","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000527080","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

Abstract

The Consortium for Medical Marijuana Clinical Outcomes Research, a multi-university collaboration established by the state of Florida in the USA, hosted its second annual Cannabis Clinical Outcomes Research Conference (CCORC) in May 2022. CCORC was held as a hybrid conference, with a scientific program consisting of in-person and virtual sessions. CCORC fostered and disseminated current research on clinical outcomes of medical marijuana while stimulating collaboration and engagement between the scientific community, policymakers, industry representatives, clinicians, and other interested stakeholders. Three themes emerged from conference sessions and speakers: (1) disentangling research findings comparing use and outcomes of medical and nonmedical cannabis, (2) addressing barriers and promoting facilitators for clinical cannabis research, and (3) resolving uncertainties around cannabis dosing. The third annual CCORC is planned for the summer of 2023 in Florida, USA.

查看原文本刊更多论文

2022年大麻临床结果研究会议论文集。

由美国佛罗里达州建立的多所大学合作的医用大麻临床结果研究联盟于2022年5月举办了第二届年度大麻临床结果研究会议(CCORC)。CCORC是一种混合会议，其科学计划包括面对面和虚拟会议。CCORC促进和传播目前关于医用大麻临床结果的研究，同时促进科学界、政策制定者、行业代表、临床医生和其他感兴趣的利益相关者之间的合作和参与。会议各届会议和发言者提出了三个主题:(1)理清比较医用和非医用大麻的使用和结果的研究结果;(2)解决大麻临床研究的障碍并促进促进因素;(3)解决大麻剂量方面的不确定性。第三届年度CCORC计划于2023年夏天在美国佛罗里达州举行。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Medical Cannabis and Cannabinoids Medicine-Complementary and Alternative Medicine

CiteScore

6.00

自引率

0.00%

发文量

审稿时长

18 weeks